These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Low-dose indomethacin after ischemic acute kidney injury prevents downregulation of Oat1/3 and improves renal outcome. Schneider R; Meusel M; Renker S; Bauer C; Holzinger H; Roeder M; Wanner C; Gekle M; Sauvant C Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1614-21. PubMed ID: 19794109 [TBL] [Abstract][Full Text] [Related]
43. Oat1/3 restoration protects against renal damage after ischemic AKI. Schneider R; Meusel M; Betz B; Held C; Möller-Ehrlich K; Büttner-Herold M; Wanner C; Gekle M; Sauvant C Am J Physiol Renal Physiol; 2015 Feb; 308(3):F198-208. PubMed ID: 25391897 [TBL] [Abstract][Full Text] [Related]
44. Angiotensin II augments medullary hypoxia and predisposes to acute renal failure. Brezis M; Greenfeld Z; Shina A; Rosen S Eur J Clin Invest; 1990 Apr; 20(2):199-207. PubMed ID: 2112485 [TBL] [Abstract][Full Text] [Related]
45. Role of the prostaglandin and kallikrein-kinin systems in aminoglycoside-induced acute renal failure. Higa EM; Schor N; Boim MA; Ajzen H; Ramos OL Braz J Med Biol Res; 1985; 18(3):355-65. PubMed ID: 2424533 [TBL] [Abstract][Full Text] [Related]
46. Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites. López-Parra M; Clària J; Planagumà A; Titos E; Masferrer JL; Woerner BM; Koki AT; Jiménez W; Altuna R; Arroyo V; Rivera F; Rodés J Br J Pharmacol; 2002 Feb; 135(4):891-900. PubMed ID: 11861316 [TBL] [Abstract][Full Text] [Related]
47. Acute effects of cyclooxygenase-2 inhibition on renal function in heterozygous ren-2-transgenic rats on normal or low sodium intake. Vanecková I; Cahová M; Kramer HJ; Husková Z; Skaroupková P; Komers R; Bader M; Ganten D; Cervenka L Kidney Blood Press Res; 2004; 27(4):203-10. PubMed ID: 15273422 [TBL] [Abstract][Full Text] [Related]
48. Effect of nebivolol, a novel beta 1-selective adrenoceptor antagonist with vasodilating properties, on kidney function. Greven J; Gabriëls G Arzneimittelforschung; 2000 Nov; 50(11):973-9. PubMed ID: 11148863 [TBL] [Abstract][Full Text] [Related]
49. Ultrapure polymerized bovine hemoglobin (UPPBHb) improves integrity of the isolated perfused rat kidney (IPRK): effects on function and structure. Willinger CC; Schramek H; Pfaller K; Pfaller W; Deetjen P Clin Nephrol; 1995 Jul; 44(1):32-43. PubMed ID: 7554531 [TBL] [Abstract][Full Text] [Related]
50. Effects of 1400W and/or nitroglycerin on renal oxygenation and kidney function during endotoxaemia in anaesthetized rats. Johannes T; Mik EG; Klingel K; Goedhart PT; Zanke C; Nohé B; Dieterich HJ; Unertl KE; Ince C Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):870-9. PubMed ID: 19413586 [TBL] [Abstract][Full Text] [Related]
51. Low-dose nitrite alleviates early effects of an X-ray contrast medium on renal hemodynamics and oxygenation in rats. Seeliger E; Cantow K; Arakelyan K; Ladwig M; Persson PB; Flemming B Invest Radiol; 2014 Feb; 49(2):70-7. PubMed ID: 24056115 [TBL] [Abstract][Full Text] [Related]
52. Renal hemodynamic effects of nabumetone, sulindac, and placebo in patients with osteoarthritis. Cangiano JL; Figueroa J; Palmer R Clin Ther; 1999 Mar; 21(3):503-12. PubMed ID: 10321419 [TBL] [Abstract][Full Text] [Related]
53. Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension. Hermann M; Shaw S; Kiss E; Camici G; Bühler N; Chenevard R; Lüscher TF; Gröne HJ; Ruschitzka F Hypertension; 2005 Feb; 45(2):193-7. PubMed ID: 15630049 [TBL] [Abstract][Full Text] [Related]
54. Effects of enhanced oxygen release from hemoglobin by RSR13 in an acute renal failure model. Burke TJ; Malhotra D; Shapiro JI Kidney Int; 2001 Oct; 60(4):1407-14. PubMed ID: 11576354 [TBL] [Abstract][Full Text] [Related]
55. Chronic effects of nitric oxide and prostaglandin inhibition on pressure diuresis and natriuresis in rats. García-Estan J; Navarro J; Atucha NM; Quesada T; Romero JC; Cachofeiro V; Lahera V Kidney Int Suppl; 1996 Jun; 55():S141-3. PubMed ID: 8743537 [TBL] [Abstract][Full Text] [Related]
56. Effect of COX inhibitors and NO on renal hemodynamics following ischemia-reperfusion injury in normotensive and hypertensive rats. Knight S; Johns EJ Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1072-7. PubMed ID: 15956774 [TBL] [Abstract][Full Text] [Related]
57. Chronic lithium treatment protects the rat kidney against ischemia/reperfusion injury: the role of nitric oxide and cyclooxygenase pathways. Talab SS; Emami H; Elmi A; Nezami BG; Assa S; Deroee AF; Daneshmand A; Tavangar SM; Dehpour AR Eur J Pharmacol; 2010 Nov; 647(1-3):171-7. PubMed ID: 20826134 [TBL] [Abstract][Full Text] [Related]
58. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats. Wang JL; Cheng HF; Shappell S; Harris RC Kidney Int; 2000 Jun; 57(6):2334-42. PubMed ID: 10844603 [TBL] [Abstract][Full Text] [Related]
59. Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway. Blanco-Rivero J; Márquez-Rodas I; Xavier FE; Aras-López R; Arroyo-Villa I; Ferrer M; Balfagón G Cardiovasc Res; 2007 Jul; 75(2):398-407. PubMed ID: 17412316 [TBL] [Abstract][Full Text] [Related]
60. Effects of nabumetone on prostanoid biosynthesis in humans. Cipollone F; Ganci A; Panara MR; Greco A; Cuccurullo F; Patrono C; Patrignani P Clin Pharmacol Ther; 1995 Sep; 58(3):335-41. PubMed ID: 7554708 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]